Outcomes of two different chemical modalities in management of post traumatic clotted hemothorax

abdrabo, mahmoud mohamed; Elsharawy, Mamdouh; Elnahal, Nezar

doi:10.21608/zumj.2021.81993.2269

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Systemic anticoagulation, prothrombin time, partial thromboplastin time, international normalized ratio, and platelet count do not appear to be risk factors for bleeding complications. One or two doses of alteplase appear most successful [32] El Sharawy et al, found that comparative results showed higher success rate of TPA protocol in comparison to SK protocol (in 100% of TPA group and 85% in SK group Intra-pleural fibrinolytic therapy with both Tissue plasminogen activator or Streptokinase were safe and successful in our patients with traumatic clotted hemothorax [35] but, in the MIST II [36]. Rahman et al trials the intrapleural TPA-DNase therapy significantly improved fluid drainage in patients with pleural infection and reduced the frequency of surgical referral and the duration of the hospital stay.…”

Section: Complicationsmentioning

confidence: 57%

Results of two fibrinolytics in treatment of the early stage of empyema

tawfek

Elsharawy

Ibrahim

et al. 2022

Zagazig University Medical Journal

View full text Add to dashboard Cite

Background: Management of an early empyema is an important problem in thoracic surgery. As an alternative to surgical treatment empyema is in patients who developed early empyema, intra-pleural fibrinolysis has been used with favorable results. This modality of treatment may reduce known morbidities secondary to surgical procedures and may result in significant medical cost savings. Our study aim is to test the efficacy and safety of tissue plasminogen activator and Streptokinase for management of early empyema. Methods: Our study included 48 patients presented with complicated parapneumonic effusion and early empyema. Patients were divided into two groups each contains 24 patients. First group treated with intra-pleural Alteplase (tissue plasminogen activator) and the second group treated with streptokinase, both were instilled via an intercostal chest tube. Clinical and radiologic (chest radiographs (CXR) and chest computed tomography (CT) data used for evaluation of efficacy of both protocols. Results: Tissue plasminogen activator give excellent results in early empyema, it showed success rate 100%, dramatic improvement in both chest tube drain and pleural thickness with no need for further surgical intervention, Streptokinase showed success rate 83.4% in comparison to TPA. Conclusion: Intrapleural tissue plasminogen activator is safe and more efficient than Streptokinase as a chemical modality in treating patients presented with complicated pleural effusion and early empyema.

show abstract

Section: Complicationsmentioning

confidence: 57%

Results of two fibrinolytics in treatment of the early stage of empyema

tawfek

Elsharawy

Ibrahim

et al. 2022

Zagazig University Medical Journal

View full text Add to dashboard Cite

show abstract

“…Lardionois and Ris (27) reported that VATS sympathectomy with a single port approach for palmar hyperhidrosis demonstrated benefits in terms of reduced postoperative pain, which raised patient satisfaction. Abdrabbo et al (28) found no patients in their study experienced severe pain following a VATS sympathectomy, and 35% of patients reported moderate pain that could be managed with oral analgesics after discharge.…”

Section: Discussionmentioning

confidence: 86%

Omitting Chest Tube Drainage after Video Assisted Thoracoscopic Surgery

Alanwar¹,

El-Sharawy²,

Brik³

et al. 2023

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: Drainless minimally invasive video-assisted thoracoscopic surgery (VATS) has improved perioperative outcomes and has become the standard of care for many thoracic procedures. Objectives: This study aimed to assess safety and perioperative outcomes of omitting chest tube drainage after VATS among eligible selected patients Methods: This study included 48 patients eligible for VATS and fulfilling the inclusion and exclusion criteria of omitting chest tube drain where, they were randomly allocated into two groups: Group-I (Drainless group) included 24 patients undergoing VATS with intra operative omitting of chest tube drains after an air leakage test and group-II (Drainage group) that included 24 patients undergoing VATS with conventional treatment using standard chest tube drainage. Results: Omitting chest tube drainage improved the median of operation time (116.0 minutes), average post-operative pain score per day (1.66) and shortened median of postoperative duration of hospital stay (1.0 days) among patients in drainless group-I compared to 139 minutes, 4.8 and 3.5 days among patient in drainage group-II (P<0.001) respectively. Uniportal VATS procedure, VATS sympathectomy, male sex, younger age and non-smoking habits in eligible selected patients with omitting chest tube drainage among them expressed significantly the lowest postoperative pain score, shortest postoperative duration of hospital stay and the least operation time with minimal risk of perioperative complications compared to drainage group-II (P<0.01). Conclusions: Omitting chest tube drainage after VATS is feasible in eligible selected patients and improved its efficacy, safety and perioperative outcomes (postoperative pain, hospital stay length, and the risk of perioperative complications).

show abstract

Outcomes of two different chemical modalities in management of post traumatic clotted hemothorax

Cited by 2 publications

References 0 publications

Results of two fibrinolytics in treatment of the early stage of empyema

Results of two fibrinolytics in treatment of the early stage of empyema

Omitting Chest Tube Drainage after Video Assisted Thoracoscopic Surgery

Contact Info

Product

Resources

About